Nutrient recovery from source-separated human urine has attracted interest as it is rich in nitrogen and phosphorus that can be utilized as fertilizer.However,urine also contains pharmaceuticals,steroid hormones,etc.and their removal is crucial as they have detrimental effects on the environment and human health.The current study focuses on investigating the degradation of pharmaceuticals using a double-chamber microbial fuel cell (MFC).Urine was spiked with four pharmaceuticals (trimethoprim,lamivudine,levofloxacin,and estrone) at a concentration of 2 μg/mL.The MFC was operated for 7 months in batch mode with this spiked urine as feed.The degradation efficiency of the MFC was studied,for which a selective liquid chromatography-tandem mass-spectrometric method was developed for the quantitation of compounds used in the spiking experiments and was validated with a lower limit of quantification of 0.39 ng/mL.The maximum removal rate achieved was 96％± 2％.The degradation mechanism involved processes like sorption and anoxic biodegradation.The voltage curve obtained showed that the presence of pharmaceuticals had an initial negative impact on power generation along with increased organic content;however,after the reactor acclimatization,increased power output was achieved with maximum organics removal at 30 h of retention time.This work opens a new perspective for the anoxic biodegradation of pharmaceuticals and can be useful in future bioremediation studies.

Background: Administering anesthesia in dentistry can be distressing for patients, especially those with dental fear and anxiety. Needle pain during local anesthesia is a common concern in intraoral procedures. This study aimed to compare pain perception in 4–6-year-old children following intraoral dental injections with 26- and 31-gauge needles. Methods: Fifty healthy children were divided according to age into Group I (N = 25; 4–5 years) and Group II (N = 25; 5–6 years). Each group was further subdivided according to the needle gauge as follows: Group IA (26 gauge), Group IB (31 gauge), Group IIA (26 gauge), and Group IIB (31 gauge). Using a lottery method, the gauge of the needle to be used at the first visit for local anesthesia administration was selected. Children’s reactions to pain were evaluated using a Modified Behavioral Pain Scale. Immediately after administration of local anesthesia, pain perception was evaluated using the Faces pain rating scale. In the subsequent visit, another needle gauge was used to administer local anesthesia, and the previously described evaluations were performed. At the third appointment, the child was shown both syringes and asked to choose one of the syringes they preferred, and the choice was noted. Results: When local anesthesia was administered using a 31-gauge needle, pain perception was similar between the two groups. In group II, the children demonstrated significantly higher arm and leg movements (P = 0.001). However, the difference was significant in group I alone (P < 0.001). Conclusion Irrespective of age, anesthesia with a 31-gauge needle resulted in significantly lower pain perception than anesthesia with a 26-gauge needle.

Treating patients undergoing chemotherapy who display findings of liver toxicity, requires a solid understanding of these medications. It is important for any clinician to have an index of suspicion for liver toxicity and be able to recognize it, even on imaging. Cancer chemotherapy has evolved, and newer medications that target cell biology have a different pattern of liver toxicity and may differ from the more traditional cytotoxic agents. There are several hepatic conditions that can result and keen clinical as well as radiographic recognition are paramount. Conditions such as sinusoidal obstructive syndrome, steatosis, and pseudocirrhosis are more commonly associated with chemotherapy. These conditions can display clinical signs of acute hepatitis, liver cirrhosis, and even liver failure. It is important to anticipate and recognize these adverse reactions and thus appropriate clinical action can be taken. Often times, patients with these liver manifestations can be managed with supportive therapies, and liver toxicity may resolve after discontinuation of chemotherapy.
Adult ; Aged ; Antibiotics, Antineoplastic/adverse effects/therapeutic use ; Antimetabolites, Antineoplastic/adverse effects/therapeutic use ; Antineoplastic Agents/*adverse effects/therapeutic use ; Antineoplastic Agents, Alkylating/adverse effects/therapeutic use ; Drug-Induced Liver Injury/etiology/radiography ; Enzyme Inhibitors/adverse effects/therapeutic use ; Fatty Liver/etiology/radiography ; Female ; Humans ; Immunotherapy ; Liver Cirrhosis/etiology/radiography ; Liver Diseases/etiology/*radiography ; Male ; Middle Aged ; Neoplasms/therapy ; Tomography, X-Ray Computed

Purpose: This study aimed to compare the anxiety, depression, and quality of life (QOL) among caregivers of children with cerebral palsy and those caring for typically developing children. Methods: A cross-sectional, comparative study was conducted using convenience sampling to recruit 60 subjects. Anxiety, depression, and QOL were assessed with the Generalized Anxiety Disorder-7 Scale, the Patient Health Questionnaire-9, and the World Health Organization Quality of Life-BREF Scale, respectively. Results: The mean age of caregivers of children with cerebral palsy was 33.63±6.94 years, compared to 32±5.003 years for caregivers of typically developing children. Caregivers of children with cerebral palsy exhibited significantly higher levels of anxiety and depression, as well as poorer QOL, than those caring for typically developing children (P<0.05). Conclusion Caregivers of children with cerebral palsy experience higher levels of anxiety and depression and a poorer QOL compared to caregivers of typically developing children.

Purpose: This study aimed to compare the anxiety, depression, and quality of life (QOL) among caregivers of children with cerebral palsy and those caring for typically developing children. Methods: A cross-sectional, comparative study was conducted using convenience sampling to recruit 60 subjects. Anxiety, depression, and QOL were assessed with the Generalized Anxiety Disorder-7 Scale, the Patient Health Questionnaire-9, and the World Health Organization Quality of Life-BREF Scale, respectively. Results: The mean age of caregivers of children with cerebral palsy was 33.63±6.94 years, compared to 32±5.003 years for caregivers of typically developing children. Caregivers of children with cerebral palsy exhibited significantly higher levels of anxiety and depression, as well as poorer QOL, than those caring for typically developing children (P<0.05). Conclusion Caregivers of children with cerebral palsy experience higher levels of anxiety and depression and a poorer QOL compared to caregivers of typically developing children.

Purpose: This study aimed to compare the anxiety, depression, and quality of life (QOL) among caregivers of children with cerebral palsy and those caring for typically developing children. Methods: A cross-sectional, comparative study was conducted using convenience sampling to recruit 60 subjects. Anxiety, depression, and QOL were assessed with the Generalized Anxiety Disorder-7 Scale, the Patient Health Questionnaire-9, and the World Health Organization Quality of Life-BREF Scale, respectively. Results: The mean age of caregivers of children with cerebral palsy was 33.63±6.94 years, compared to 32±5.003 years for caregivers of typically developing children. Caregivers of children with cerebral palsy exhibited significantly higher levels of anxiety and depression, as well as poorer QOL, than those caring for typically developing children (P<0.05). Conclusion Caregivers of children with cerebral palsy experience higher levels of anxiety and depression and a poorer QOL compared to caregivers of typically developing children.

Purpose: This study aimed to compare the anxiety, depression, and quality of life (QOL) among caregivers of children with cerebral palsy and those caring for typically developing children. Methods: A cross-sectional, comparative study was conducted using convenience sampling to recruit 60 subjects. Anxiety, depression, and QOL were assessed with the Generalized Anxiety Disorder-7 Scale, the Patient Health Questionnaire-9, and the World Health Organization Quality of Life-BREF Scale, respectively. Results: The mean age of caregivers of children with cerebral palsy was 33.63±6.94 years, compared to 32±5.003 years for caregivers of typically developing children. Caregivers of children with cerebral palsy exhibited significantly higher levels of anxiety and depression, as well as poorer QOL, than those caring for typically developing children (P<0.05). Conclusion Caregivers of children with cerebral palsy experience higher levels of anxiety and depression and a poorer QOL compared to caregivers of typically developing children.